Back to Stocks
Rank #1616SVRA
Savara, Inc.
$5.72
2.33% (Daily)
Market Cap
$1.16B
Revenue
$N/A
Rank by MCap
#1616
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Matthew Pauls J.D., M.B.A.
Headquarters
Langhorne, PA
Employees
59
About Savara, Inc.
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in 2007 and is headquartered in Langhorne, Pennsylvania.
Savara, Inc. Price Chart
Loading chart…